|1.||Rosenberg, Lawrence: 2 articles (11/2004 - 11/2004)|
|2.||Tam, Joseph: 1 article (11/2004)|
|3.||Lipsett, Mark: 1 article (11/2004)|
|4.||Vinik, Aaron I: 1 article (11/2004)|
|5.||Maysinger, Dusica: 1 article (11/2004)|
|6.||Pittenger, Gary L: 1 article (11/2004)|
|7.||Jun, Hee-Sook: 1 article (11/2004)|
|8.||Yoon, Ji-Won: 1 article (11/2004)|
|9.||Taylor-Fishwick, David: 1 article (11/2004)|
|10.||Wang, Rennian: 1 article (11/2004)|
|2.||Peripheral Nervous System Diseases (PNS Diseases)
11/01/2004 - "The objective of this study was to demonstrate that islet neogenesis-associated protein (INGAP) peptide, a pentadecapeptide containing the biologically active portion of native INGAP, increases functional beta-cell mass in normal animals and can be used therapeutically to reverse hyperglycemia in streptozotocin-induced diabetes. "
11/01/2004 - "Diabetic mice treated with exendin-4 or a scrambled INGAP peptide did not revert from hyperglycemia. "
11/01/2004 - "Two additional groups of diabetic mice were administered either a peptide composed of a scrambled sequence of amino acids from INGAP peptide (n = 5) or exendin-4 (n = 5), an incretin that has been associated with amelioration of hyperglycemia. "
|6.||tranilast (N 5')